Health
GLP-1 Drugs Shift Focus
GLP-1 drugs, once seen as treatments for obesity, are now marketed as lifestyle enhancers. This shift has affected pharmaceutical giants Merck and Daiichi.
Coverage timeline — 1 article
STAT News
Once promoted as tools to address obesity as a medical issue, GLP-1 drugs are increasingly being seen — and marketed — as a way to look and feel better
2026-09-28 13:06 UTC